OCT 24, 2018 10:30 AM PDT

Chemometric Methods for Analysis of 2D 1H-13C Methyl NMR Spectra of Monoclonal Antibodies for Higher Order Structure Characterization

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Research Chemist, Macromolecular Structure and Function Group, National Institute of Standards and Technology (NIST)
    Biography
      Luke W. Arbogast is a Research Chemist in the Biomolecular Measurement Division at the National Institute of Standards and Technology (NIST). His current research focuses on the development and application of state-of-the-art two-dimensional NMR methods to characterize the structure of protein therapeutics. These methods are of particular interest to the biopharmaceutical industry where structural comparability studies are necessary for drug development, drug-quality testing and the benchmarking biosimilars against innovator reference products. In 2016, Luke received the Department of Commerce Silver Award for his work in this area. Prior to his current role at NIST, Luke was a National Research Council Postdoctoral Fellow at the Institute for Bioscience and Biotechnology Research in Rockville, Md. Luke received his B.S. in Chemistry from Virginia Commonwealth University and his Ph.D. in Chemistry from Johns Hopkins University.

    Abstract:

    Two-dimensional (2D) 1H-13C methyl correlated NMR is increasingly being recognized as a powerful tool to characterize the higher order structure (HOS) of monoclonal antibody (mAb) therapeutics. 2D methyl NMR is well suited to the task as spectra can be readily be acquired on intact mAbs at natural isotopic abundance, and even small changes to chemical environment and structure manifest observable changes in the spectra, which can be interpreted at atomic resolution. This makes it possible to apply 2D NMR approaches directly to drug products in order to systematically characterize structural effects. Traditionally, such analysis has involved identifying specific changes to measured resonance peak parameters.  Recently, we have demonstrated a complementary approach using principal component analysis (PCA) to directly analyze the matrix of spectral data, correlating spectra according to similarities and differences in their overall shapes. This approach is particularly well-suited for spectra of mAbs, where many individual peaks may not be well resolved and peak parameters difficult to measure. Here we demonstrate the performance of the PCA method for discriminating structural variation among systematic sets of 2D NMR spectra using the NISTmAb reference material and illustrate how spectral variability identified by PCA may be correlated to structure.

    Learning Objectives: 

    1. 2D 1H-13C Methyl NMR spectra can be readily acquired on monoclonal antibody therapeutics at natural isotopic abundance.
    2. Such spectra are suitable to assess the major conformation(s) of mAb drugs in solution.
    3. Using multivariate statistics, such as principal component analysis mAb spectra can be classified based on minor structural perturbations with low levels of detection.


    Show Resources
    You May Also Like
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 05, 2018 06:30 AM PDT
    C.E. CREDITS
    JUN 05, 2018 06:30 AM PDT
    DATE: June 5, 2018TIME: 06:30AM PDT, 3:30PM CEST Viscous liquids are a challenge in every lab that deals with them. Depending on how viscous a liquid is, pipetting is either...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    DEC 11, 2018 10:00 AM PST
    C.E. CREDITS
    DEC 11, 2018 10:00 AM PST
    DATE: December 11, 2018TIME: 11:00 PSTThis webinar will focus on how Reichert's Surface Plasmon Resonance (SPR) systems can generate additional valuable information that is not...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    Loading Comments...